版本:
中国

BRIEF-Pfizer announces positive top-line results from the pivotal comparative reflections B3271002 study for PF-05280014

Nov 30 Pfizer Inc

* Pfizer announces positive top-line results from the pivotal comparative reflections B3271002 study for PF-05280014, a potential biosimilar to Herceptin1 (Trastuzumab) Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐